Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by Dandy07on May 05, 2020 2:01pm

181 Views

Post# 30988893

Interesting news..Alexion acquiring Portola

Anyone else who has other plays in the biotech sector. Alexion is acquiring Portola Pharmaceuticals for 1.41 Bill.

Of course with ico being partnered with Alexion, there's always a possibilty that if iCo has something worthwhile (ie. Oral Amp B is what I am referring to) then there's always that potential. Of course I am just speculating, as that is anyone's ultimate dream is a buyout. Long way to go, but don't give up your shares just yet. Good luck to everyone.

https://www.businesswire.com/news/home/20200505005333/en/Alexion-Acquire-Portola

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024